AVITA Medical, Inc.
AVHHL
$0.85
$0.1216.50%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.96% | 11.45% | 20.59% | 38.32% | 41.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.96% | 11.45% | 20.59% | 38.32% | 41.35% |
| Cost of Revenue | 29.47% | 40.68% | 36.69% | 56.27% | 36.56% |
| Gross Profit | -3.89% | 6.63% | 17.89% | 35.42% | 42.20% |
| SG&A Expenses | -14.09% | -11.90% | -6.14% | 10.15% | 25.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.97% | -5.54% | -3.75% | 12.04% | 22.09% |
| Operating Income | 22.85% | 24.84% | 28.56% | 14.10% | -2.54% |
| Income Before Tax | 20.46% | 21.38% | 15.30% | -3.67% | -27.40% |
| Income Tax Expenses | -128.13% | -81.48% | -2.13% | -96.51% | -51.52% |
| Earnings from Continuing Operations | 20.52% | 21.44% | 15.29% | -3.50% | -27.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.52% | 21.44% | 15.29% | -3.50% | -27.28% |
| EBIT | 22.85% | 24.84% | 28.56% | 14.10% | -2.54% |
| EBITDA | 25.43% | 27.45% | 30.99% | 16.23% | -1.07% |
| EPS Basic | 28.36% | 26.80% | 18.62% | -1.31% | -24.60% |
| Normalized Basic EPS | 29.71% | 29.80% | 28.96% | 13.91% | -4.14% |
| EPS Diluted | 28.36% | 26.80% | 18.62% | -1.31% | -24.60% |
| Normalized Diluted EPS | 29.71% | 29.80% | 28.96% | 13.91% | -4.14% |
| Average Basic Shares Outstanding | 11.08% | 7.60% | 4.18% | 2.42% | 2.35% |
| Average Diluted Shares Outstanding | 11.08% | 7.60% | 4.18% | 2.42% | 2.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |